TMEM135 deficiency improves hepatic steatosis by suppressing CD36 in a SIRT1-dependent manner

Objectives: Dysregulation of lipid homeostasis pathway causes many liver diseases, including hepatic steatosis. One of the primary factors contributing to lipid accumulation is fatty acid uptake by the liver. Transmembrane protein 135 (TMEM135), which exists in mitochondria and peroxisomes, particip...

Full description

Saved in:
Bibliographic Details
Main Authors: Arun Chhetri, Channy Park, Hyunsoo Kim, Laxman Manandhar, Chagtsalmaa Chuluunbaatar, Jaetaek Hwang, Xiaofan Wei, Gyuho Jang, Batching Chinbold, Hyug Moo Kwon, Sang-wook Lee, Raekil Park
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Molecular Metabolism
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2212877824002114
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832575462915702784
author Arun Chhetri
Channy Park
Hyunsoo Kim
Laxman Manandhar
Chagtsalmaa Chuluunbaatar
Jaetaek Hwang
Xiaofan Wei
Gyuho Jang
Batching Chinbold
Hyug Moo Kwon
Sang-wook Lee
Raekil Park
author_facet Arun Chhetri
Channy Park
Hyunsoo Kim
Laxman Manandhar
Chagtsalmaa Chuluunbaatar
Jaetaek Hwang
Xiaofan Wei
Gyuho Jang
Batching Chinbold
Hyug Moo Kwon
Sang-wook Lee
Raekil Park
author_sort Arun Chhetri
collection DOAJ
description Objectives: Dysregulation of lipid homeostasis pathway causes many liver diseases, including hepatic steatosis. One of the primary factors contributing to lipid accumulation is fatty acid uptake by the liver. Transmembrane protein 135 (TMEM135), which exists in mitochondria and peroxisomes, participates in intracellular lipid metabolism. This study aims to investigate the role of TMEM135 on regulating cellular lipid import in the liver. Methods: We used in vivo, ex vivo, and in vitro models of steatosis. TMEM135 knockout (TMEM135KO) and wild type (WT) mice were fed a high-fat diet (HFD) to induce hepatic steatosis. Primary mouse hepatocytes and AML12 cells were treated with free fatty acid (FFA). Additionally, TMEM135-deficient stable cells and overexpressed cells were established using AML12 cells. Results: TMEM135 deficiency mitigated lipid accumulation in the liver of HFD-fed TMEM135KO mice. TMEM135-depleted primary hepatocytes and AML12 cells exhibited less lipid accumulation when treated with FFA compared to control cells, as shown as lipid droplets. Consistently, the effect of TMEM135 depletion on lipid accumulation was completely reversed under TMEM135 overexpression conditions. CD36 expression was markedly induced by HFD or FFA, which was reduced by TMEM135 depletion. Among the SIRT family proteins, only SIRT1 expression definitely increased in the liver of HFD-fed TMEM135KO mice along with a significant increase in NAD+/NADH ratio. However, inhibition of SIRT1 in TMEM135-depleted cells using siSIRT1 or the SIRT1 inhibitor EX-527 resulted in an increase of CD36 expression and consequent TG levels. Conclusions: TMEM135 depletion attenuates CD36 expression in a SIRT1-dependent manner, thereby reducing cellular lipid uptake and hepatic steatosis.
format Article
id doaj-art-855adc47393d4233a903ed8b4092b367
institution Kabale University
issn 2212-8778
language English
publishDate 2025-02-01
publisher Elsevier
record_format Article
series Molecular Metabolism
spelling doaj-art-855adc47393d4233a903ed8b4092b3672025-02-01T04:11:56ZengElsevierMolecular Metabolism2212-87782025-02-0192102080TMEM135 deficiency improves hepatic steatosis by suppressing CD36 in a SIRT1-dependent mannerArun Chhetri0Channy Park1Hyunsoo Kim2Laxman Manandhar3Chagtsalmaa Chuluunbaatar4Jaetaek Hwang5Xiaofan Wei6Gyuho Jang7Batching Chinbold8Hyug Moo Kwon9Sang-wook Lee10Raekil Park11Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of KoreaDepartment of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of KoreaDepartment of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of KoreaDepartment of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of KoreaDepartment of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of KoreaDepartment of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of KoreaDepartment of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of KoreaDepartment of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of KoreaDepartment of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of KoreaSchool of Life Sciences, Ulsan National Institute of Science and Technology, Ulsan, Republic of KoreaDepartment of Radiation Oncology Asan Medical Center, Seoul, Republic of KoreaDepartment of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea; Corresponding author. Department of Biomedical Science & Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea.Objectives: Dysregulation of lipid homeostasis pathway causes many liver diseases, including hepatic steatosis. One of the primary factors contributing to lipid accumulation is fatty acid uptake by the liver. Transmembrane protein 135 (TMEM135), which exists in mitochondria and peroxisomes, participates in intracellular lipid metabolism. This study aims to investigate the role of TMEM135 on regulating cellular lipid import in the liver. Methods: We used in vivo, ex vivo, and in vitro models of steatosis. TMEM135 knockout (TMEM135KO) and wild type (WT) mice were fed a high-fat diet (HFD) to induce hepatic steatosis. Primary mouse hepatocytes and AML12 cells were treated with free fatty acid (FFA). Additionally, TMEM135-deficient stable cells and overexpressed cells were established using AML12 cells. Results: TMEM135 deficiency mitigated lipid accumulation in the liver of HFD-fed TMEM135KO mice. TMEM135-depleted primary hepatocytes and AML12 cells exhibited less lipid accumulation when treated with FFA compared to control cells, as shown as lipid droplets. Consistently, the effect of TMEM135 depletion on lipid accumulation was completely reversed under TMEM135 overexpression conditions. CD36 expression was markedly induced by HFD or FFA, which was reduced by TMEM135 depletion. Among the SIRT family proteins, only SIRT1 expression definitely increased in the liver of HFD-fed TMEM135KO mice along with a significant increase in NAD+/NADH ratio. However, inhibition of SIRT1 in TMEM135-depleted cells using siSIRT1 or the SIRT1 inhibitor EX-527 resulted in an increase of CD36 expression and consequent TG levels. Conclusions: TMEM135 depletion attenuates CD36 expression in a SIRT1-dependent manner, thereby reducing cellular lipid uptake and hepatic steatosis.http://www.sciencedirect.com/science/article/pii/S2212877824002114TMEM135Lipid accumulationCD36SIRT1
spellingShingle Arun Chhetri
Channy Park
Hyunsoo Kim
Laxman Manandhar
Chagtsalmaa Chuluunbaatar
Jaetaek Hwang
Xiaofan Wei
Gyuho Jang
Batching Chinbold
Hyug Moo Kwon
Sang-wook Lee
Raekil Park
TMEM135 deficiency improves hepatic steatosis by suppressing CD36 in a SIRT1-dependent manner
Molecular Metabolism
TMEM135
Lipid accumulation
CD36
SIRT1
title TMEM135 deficiency improves hepatic steatosis by suppressing CD36 in a SIRT1-dependent manner
title_full TMEM135 deficiency improves hepatic steatosis by suppressing CD36 in a SIRT1-dependent manner
title_fullStr TMEM135 deficiency improves hepatic steatosis by suppressing CD36 in a SIRT1-dependent manner
title_full_unstemmed TMEM135 deficiency improves hepatic steatosis by suppressing CD36 in a SIRT1-dependent manner
title_short TMEM135 deficiency improves hepatic steatosis by suppressing CD36 in a SIRT1-dependent manner
title_sort tmem135 deficiency improves hepatic steatosis by suppressing cd36 in a sirt1 dependent manner
topic TMEM135
Lipid accumulation
CD36
SIRT1
url http://www.sciencedirect.com/science/article/pii/S2212877824002114
work_keys_str_mv AT arunchhetri tmem135deficiencyimproveshepaticsteatosisbysuppressingcd36inasirt1dependentmanner
AT channypark tmem135deficiencyimproveshepaticsteatosisbysuppressingcd36inasirt1dependentmanner
AT hyunsookim tmem135deficiencyimproveshepaticsteatosisbysuppressingcd36inasirt1dependentmanner
AT laxmanmanandhar tmem135deficiencyimproveshepaticsteatosisbysuppressingcd36inasirt1dependentmanner
AT chagtsalmaachuluunbaatar tmem135deficiencyimproveshepaticsteatosisbysuppressingcd36inasirt1dependentmanner
AT jaetaekhwang tmem135deficiencyimproveshepaticsteatosisbysuppressingcd36inasirt1dependentmanner
AT xiaofanwei tmem135deficiencyimproveshepaticsteatosisbysuppressingcd36inasirt1dependentmanner
AT gyuhojang tmem135deficiencyimproveshepaticsteatosisbysuppressingcd36inasirt1dependentmanner
AT batchingchinbold tmem135deficiencyimproveshepaticsteatosisbysuppressingcd36inasirt1dependentmanner
AT hyugmookwon tmem135deficiencyimproveshepaticsteatosisbysuppressingcd36inasirt1dependentmanner
AT sangwooklee tmem135deficiencyimproveshepaticsteatosisbysuppressingcd36inasirt1dependentmanner
AT raekilpark tmem135deficiencyimproveshepaticsteatosisbysuppressingcd36inasirt1dependentmanner